CRISPR Therapeutics AG (CRSP) Tax Rate (2015 - 2026)
CRISPR Therapeutics AG's (CRSP) quarterly Tax Rate came in at 1.11% in Q2 2026, down 48.0% year-over-year from 2.13% in Q2 2025, and down 61.34% quarter-over-quarter from 0.69% in Q1 2026.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Tax Rate (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has disclosed Tax Rate across 12 years of filings, most recently posting 1.11% for Q2 2026.
- In Q2 2026, Tax Rate fell 48.0% year-over-year to 1.11%; the TTM figure through Jun 2026 stood at 0.64% (up 25.0% YoY), while the FY2025 annual figure was 0.6%, up 41.0% from the prior year.
- Tax Rate came in at 1.11% for Q2 2026 at CRISPR Therapeutics AG, down from 0.69% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 7.02% in Q4 2022 to a low of 3.4% in Q2 2022.
- Average Tax Rate over 5 years is 0.53%, with a median of 0.75% recorded in 2025.
- Year-over-year, Tax Rate soared 545 bps in 2022 and slumped 598 bps in 2023.
- Over 5 years, Tax Rate stood at 7.02% in 2022, then plunged by 85 bps to 1.03% in 2023, then tumbled by 246 bps to 1.5% in 2024, then surged by 75 bps to 0.38% in 2025, then tumbled by 193 bps to 1.11% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 1.11% in Q2 2026, 0.69% in Q1 2026, and 0.38% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.36 Bn | 112.79 Mn | 17.12% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -1.11% |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.50 Bn | 55.72 Mn | 2.88% |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | -40.18% |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | -2.32% |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -179.59% |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | - |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11% |
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | -0.38% |
| Sep 30, 2025 | -0.58% |
| Jun 30, 2025 | -0.63% |
| Mar 31, 2025 | -0.82% |
| Dec 31, 2024 | -1.50% |
| Sep 30, 2024 | -1.06% |
| Jun 30, 2024 | -1.04% |
| Mar 31, 2024 | -0.62% |
| Dec 31, 2023 | 1.03% |
| Sep 30, 2023 | -0.37% |
| Jun 30, 2023 | -1.20% |
| Mar 31, 2023 | -2.55% |
| Dec 31, 2022 | 7.02% |
| Sep 30, 2022 | 0.34% |
| Jun 30, 2022 | -3.40% |
| Mar 31, 2022 | -2.05% |
| Dec 31, 2021 | 1.57% |
| Sep 30, 2021 | 0.47% |